DT&Sanomedics, a CRO (Clinical Trial Organization) company, announced that it successfully hosted a booth and promoted the company at ‘Bio Korea 5’ held at COEX for three days from May 10th to 12th.
DT&Sanomedics set up a booth in Hall C, O29, and promoted clinical trials and consulting of medicines, medical devices, and health functional foods. The company attracted the attention of visitors by explaining in detail the clinical process from non-clinical to clinical, one-stop, and the types of clinical trials at each stage.
DT&Sanomedics is characterized by providing comprehensive services ranging from phases 1 to 3 of clinical trials, clinical trials (PMS), and pharmacovigilance (PV). In addition, it provides integrated clinical trial consulting in all areas, including monitoring of global clinical trials, project management services, and quality assurance.
CEO Seo Han-seok said, “For three days, we conducted consulting for clinical trial consulting for pharmaceuticals and medical devices and health functional food launches for not only domestic pharmaceutical and bio companies, but also global pharmaceutical bio companies such as the US, Europe, and China.” According to the achievements of the companies, various companies and officials came and felt the passion to cast their votes in the pharmaceutical market.”
Meanwhile, the secretariat that hosted ‘Bio Korea 2023’ reported that 51 companies from 729 countries participated this year and more than 2 visitors visited. Bio Korea, which celebrated its 18th anniversary this year, presented a direction for the biohealth industry to develop into a convergence and future core strategic industry after the COVID-19 pandemic under the theme of ‘A hyper-connected era, a leap into new growth innovative technology’. The event recorded a record of 2 visitors, and the conference was centered on the site with 9,400 speakers from 11 countries in 21 sessions on 13 themes.